EEF1D

Across TCGA pan-cancer cohorts, EEF1D mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated EEF1D data layer compared with 25 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher EEF1D mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated EEF1D expression acts as an unfavorable survival marker, although some lineages such as HNSC and COAD show a favorable association.

CCRCC, HNSC, and GBM are the cancer types where EEF1D mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Tertile	All	0.700	0.936	.003	32	view →
HNSC	DFS	Median	III,IV	0.729	0.509	.013	14	view →
GBM	DFS	Quartile	All	0.211	0.376	.023	8	view →
COAD	DFS	Median	IV	1.000	0.605	.043	6	view →
PDAC	OS	Quartile	III,IV	0.977	0.390	.011	5	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

EEF1D–CCRCC (OS)

Open the CCRCC breakdown →